US Bancorp
SRGA

US Bancorp’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

US Bancorp’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed -$5K – 3921
2020
Q2 		$5K Hold
50
– – ﹤0.01% 3350
2020
Q1 		$3K Hold
50
– – ﹤0.01% 3418
2019
Q4 		$4K Hold
50
– – ﹤0.01% 3367
2019
Q3 		$4K Hold
50
– – ﹤0.01% 3313
2019
Q2 		$6K Sell
50
-96
-66% -$13.8K ﹤0.01% 3256
2019
Q1 		$26K Hold
146
– – ﹤0.01% 2764
2018
Q4 		$16K Hold
146
– – ﹤0.01% 2907
2018
Q3 		$20K Hold
146
– – ﹤0.01% 2928
2018
Q2 		$20K Hold
146
– – ﹤0.01% 2939
2018
Q1 		$20K Hold
146
– – ﹤0.01% 2946
2017
Q4 		$18K Sell
146
-102
-41% -$14K ﹤0.01% 2968
2017
Q3 		$34K Buy
248
+102
+70% +$15.4K ﹤0.01% 2725
2017
Q2 		$26K Buy
146
+33
+29% +$4.69K ﹤0.01% 2807
2017
Q1 		$14K Buy
113
+21
+23% +$2.19K ﹤0.01% 2951
2016
Q4 		$9K Hold
92
– – ﹤0.01% 3063
2016
Q3 		$9K Hold
92
– – ﹤0.01% 3036
2016
Q2 		$10K Hold
92
– – ﹤0.01% 3009
2016
Q1 		$11K Sell
92
-137
-60% -$14.4K ﹤0.01% 2981
2015
Q4 		$27K Hold
229
– – ﹤0.01% 2714
2015
Q3 		$39K Hold
229
– – ﹤0.01% 2584
2015
Q2 		$44K Hold
229
– – ﹤0.01% 2591
2015
Q1 		$34K Buy
229
+177
+340% +$26.9K ﹤0.01% 2729
2014
Q4 		$8K Sell
52
-6
-10% -$864 ﹤0.01% 3180
2014
Q3 		$8K Hold
58
– – ﹤0.01% 3117
2014
Q2 		$8K Sell
58
-7
-11% -$889 ﹤0.01% 3125
2014
Q1 		$8K Hold
65
– – ﹤0.01% 3105
2013
Q4 		$7K Hold
65
– – ﹤0.01% 3079
2013
Q3 		$7K Sell
65
-233
-78% -$26.4K ﹤0.01% 2970
2013
Q2 		$33K Buy
+298
New +$36.4K ﹤0.01% 2470

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

US Bancorp's SRGA Position: Q3 2020 in Review

US Bancorp sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2020, closing a stake of 50 shares — an estimated $5K sold.

US Bancorp first reported a position in SRGA in Q2 2013 and held it in 29 quarters. The position peaked at $44K in Q2 2015. 89 funds tracked by Wall St. Rank hold SRGA as of Q3 2020.

  • US Bancorp reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • US Bancorp sold 50 Surgalign Holdings, Inc. Common Stock shares in Q3 2020, an estimated $5K.
  • US Bancorp first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 29 quarters.
  • US Bancorp's Surgalign Holdings, Inc. Common Stock position peaked at $44K in Q2 2015.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2020.

Based on US Bancorp's 13F filing for Q3 2020, filed 10 Nov 2020.